Pulmonary Embolism Following Covishield (ChADOx1 nCov-19) Vaccine: An Unusual Presentation
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 1 | Views: 246 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Case Studies | Medicine | India | Volume 12 Issue 1, January 2023 | Popularity: 4.3 / 10


     

Pulmonary Embolism Following Covishield (ChADOx1 nCov-19) Vaccine: An Unusual Presentation

Dr Sushant P Wagaj, Dr. C. A. Kante


Abstract: Pulmonary embolism is a medical emergency. Most common risk factors-immobility, malignancy, pregnancy, surgery, cigarette smoking, hypertension, obesity and in Indian population hyperhomocysteinemia. COVID infection represents a prothrombotic state but introduction of COVID vaccines to a lesser extent increased the risk of unprovoked venous thrombosis and pulmonary thrombosis.


Keywords: COVID vaccine, pulmonary embolism


Edition: Volume 12 Issue 1, January 2023


Pages: 853 - 854


DOI: https://www.doi.org/10.21275/SR22522204713


Please Disable the Pop-Up Blocker of Web Browser

Verification Code will appear in 2 Seconds ... Wait



Text copied to Clipboard!
Dr Sushant P Wagaj, Dr. C. A. Kante, "Pulmonary Embolism Following Covishield (ChADOx1 nCov-19) Vaccine: An Unusual Presentation", International Journal of Science and Research (IJSR), Volume 12 Issue 1, January 2023, pp. 853-854, https://www.ijsr.net/getabstract.php?paperid=SR22522204713, DOI: https://www.doi.org/10.21275/SR22522204713

Top